Home / Companies / Innovative Cellular Therapeutics Inc / Wages
Innovative Cellular Therapeutics Inc H-1B wage rows
Compensation-first LCA rows for Innovative Cellular Therapeutics Inc, including offered wage, annualized wage, worksite, SOC code, fiscal year, QA flags, and source record evidence. Showing 12 returned rows using keyset pagination.
Summary
This view lists 12 H-1B LCA wage observations.
Offered wages among the returned rows range from $57,720 to $152,000.
Employers in the returned rows include Innovative Cellular Therapeutics, Inc..
LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Returned-page wage summary
| Scope | returned_page |
| Count | 12 |
| Annualized Min | 57,720 |
| Annualized P25 | 69,285 |
| Annualized Median | 72,862 |
| Annualized P75 | 80,000 |
| Annualized P90 | 95,805 |
| Annualized Max | 142,000 |
| Outlier Count | 0 |
| Role | Employer | SOC | Fiscal year | Worksite | Annualized offer | Spread | QA flags | Source |
|---|---|---|---|---|---|---|---|---|
| Associate Director I-200-25188-155271 | Innovative Cellular Therapeutics, Inc. | 19-1021.00 Biochemists and Biophysicists | FY2025 Q4 | Rockville, MD, 20850 | $80,000 to $90,000 year | $16,310 | - | sr_dol_oflc_lca_2025_q4_row_100147 |
| Quality Control Manager I-200-25154-047865 | Innovative Cellular Therapeutics, Inc. | 17-2031.00 Bioengineers and Biomedical Engineers | FY2025 Q3 | Rockville, MD, 20850 | $95,805 to $105,000 year | $0 | - | sr_dol_oflc_lca_2025_q3_row_056292 |
| Chief Scientific Officer I-200-25154-047464 | Innovative Cellular Therapeutics, Inc. | 11-9121.00 Natural Sciences Managers | FY2025 Q3 | Rockville, MD, 20850 | $142,000 to $152,000 year | $789 | - | sr_dol_oflc_lca_2025_q3_row_057347 |
| Quality Control Manager I-200-24299-432874 | Innovative Cellular Therapeutics, Inc. | 17-2031.00 Bioengineers and Biomedical Engineers | FY2025 Q1 | Rockville, MD, 20850 | $79,997 year | $0 | missing_offer_high | sr_dol_oflc_lca_2025_q1_row_065594 |
| Cell Production Specialist I-200-24299-432867 | Innovative Cellular Therapeutics, Inc. | 19-1029.02 Molecular and Cellular Biologists | FY2025 Q1 | Rockville, MD, 20850 | $63,440 year | $0 | missing_offer_high | sr_dol_oflc_lca_2025_q1_row_066527 |
| Manager of Clinical Testing I-200-24162-089624 | Innovative Cellular Therapeutics, Inc. | 19-1029.02 Molecular and Cellular Biologists | FY2024 Q3 | Rockville, MD, 20850 | $72,862 to $82,862 year | $0 | - | sr_dol_oflc_lca_2024_q3_row_035818 |
| Cell Production Specialist I-200-24162-090865 | Innovative Cellular Therapeutics, Inc. | 19-1029.02 Molecular and Cellular Biologists | FY2024 Q3 | Rockville, MD, 20850 | $72,862 to $82,862 year | $0 | - | sr_dol_oflc_lca_2024_q3_row_036017 |
| Senior Manager of Clinical Testing I-200-24145-033882 | Innovative Cellular Therapeutics, Inc. | 11-9121.00 Natural Sciences Managers | FY2024 Q3 | Rockville, MD, 20850 | $95,000 to $125,000 year | $345 | - | sr_dol_oflc_lca_2024_q3_row_074926 |
| Validation & Regulatory Affairs Engineer I-200-24143-023549 | Innovative Cellular Therapeutics, Inc. | 17-2112.02 Validation Engineers | FY2024 Q3 | Rockville, MD, 20850 | $77,355 to $80,000 year | $0 | - | sr_dol_oflc_lca_2024_q3_row_081961 |
| Production Supervisor I-200-23131-013583 | Innovative Cellular Therapeutics, Inc. | 19-1029.02 Molecular and Cellular Biologists | FY2023 Q3 | Rockville, MD, 20850 | $69,285 year | $0 | missing_offer_high | sr_dol_oflc_lca_2023_q3_row_088802 |
| Quality Control Manager I-200-23131-013541 | Innovative Cellular Therapeutics, Inc. | 17-2031.00 Bioengineers and Biomedical Engineers | FY2023 Q3 | Rockville, MD, 20850 | $72,176 to $78,000 year | $0 | - | sr_dol_oflc_lca_2023_q3_row_088820 |
| Project Manager I-200-22137-180825 | Innovative Cellular Therapeutics, Inc. | 19-1021.00 Biochemists and Biophysicists | FY2022 Q3 | Rockville, MD, 20850 | $57,720 to $70,000 year | $0 | - | sr_dol_oflc_lca_2022_q3_row_132129 |
End of returned pageReset
Frequently asked questions
- What are the offered H-1B wages for Innovative Cellular Therapeutics Inc H-1B wage rows?
- Offered wages among the returned Innovative Cellular Therapeutics Inc H-1B wage rows rows range from $57,720 to $152,000 in DOL LCA filings. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Get this page with API
Rendered from the bluedoor H-1B Jobs API. Reproduce it:
GET https://api.bluedoor.sh/h1b-jobs/v1/wages?limit=50&company=innovative+cellular+therapeutics+incJSON